Direct contract access to standardized assays, pharmacological assessment models, and full-spectrum potency evaluation matrices.
Phytomedicine is undergoing an unprecedented renaissance fueled by high-resolution bio-analytics, network pharmacology, and stringent global regulatory expectations across North America, Europe, and Asia-Pacific.
Traditional pharmacognosy evaluated extracts as black boxes. Modern contract research harnesses metabolomics, transcriptomics, and in-silico target prediction to identify synergisms within multi-component botanical matrices.
Global pharmaceutical corporations and Tier-1 nutraceutical brands are abandoning fragmented brokers. They require fully auditable supply chains with documented botanical voucher specimens and verified chromatographic fingerprints.
Whether navigating the FDA Botanical Drug Guidance (21 CFR Part 314), EMA Herbal Medicinal Product Committee (HMPC) Monographs, or NMPA Innovative TCM Class 1.1/1.2, compliance begins at the molecular characterization stage.
By converging intelligent automated controls with colossal agricultural sourcing ecosystems, MedGence eliminates supply volatility while guaranteeing superior extraction kinetics and competitive cost-in-use.
Dynamic solvent gradient systems with automated PLC control maximize transfer yield of target polyphenols, alkaloids, and saponins while cutting thermal degradation by over 42%.
Zero-residue green solvent processing allows precision isolation of delicate terpene fractions and lipophilic actives without toxic residual solvents, complying with EU clean-label mandates.
Process Analytical Technology (PAT) coupled with near-infrared (NIR) and in-line HPLC ensures active content parameters are monitored in real time, preventing out-of-spec batches.
Strategically situated in Hunan, China, with long-term GAP-certified cultivation bases across diverse climatic zones, securing seasonal stability and mitigating global price volatility.
A rigorous, reproducible track record built in collaboration with Tier-1 pharmaceutical conglomerates, state TCM clinical research academies, and international research universities.
From initial bio-prospecting to pilot refinement and cGMP commercial manufacturing, our technical infrastructure provides unmatched scientific rigor at every juncture.
High-resolution screening of alkaloids, polyphenols, polysaccharides, and saponins. Utilizing proprietary bioactive databases to cross-reference targets, optimize potency, and reduce environmental harvesting impact.
View technical scope →
Botanical secondary metabolites vary drastically depending on soil composition, solar exposure, and harvest dates. We evaluate and establish geo-authentic sourcing standards to lock in raw potency.
View technical scope →
Development and validation of HPTLC identity standards, quantitative HPLC/UPLC assays, GC-MS volatile profiles, and chromatographic fingerprinting that conform with USP, Ph. Eur., and ChP specifications.
View technical scope →
Industrial design of extraction kinetics, resin adsorption-desorption dynamics, membrane purification, and vacuum low-temperature crystallization. Ensuring yield reproducibility when scaling to metric tons.
View technical scope →
Overcoming botanical formulation bottlenecks: hygroscopicity, poor bioavailability, unpleasant odor/bitterness, and unstable active compound degradation. Precision micro-encapsulation and solubility enhancement.
View technical scope →
Comprehensive toxicology profiles required for global drug files and high-tier health supplements: acute oral toxicity (LD50), 28/90-day sub-chronic toxicity, Ames bacterial reverse mutation, and micronucleus assays.
View technical scope →
Primary cell and immortalized cell line assays to quantify anti-inflammatory pathways (COX-2, TNF-α, IL-6), antioxidant mechanisms (Nrf2/ARE), glucose uptake modulation, and melanogenesis inhibition.
View technical scope →
GLP-compliant animal disease modeling (metabolic syndrome, cognitive health, cardiovascular profiles, immune regulation) providing statistical proof of bio-efficacy and in-vivo safety documentation.
View technical scope →
GCP-compliant clinical design and execution: from small-cohort randomized double-blind placebo-controlled human efficacy studies for food supplements to multi-center Phase I–IV trials for IND/NDA filings.
View technical scope →
Modernization of classical phytotherapy prescriptions. Utilizing response surface methodology (RSM) to pinpoint synergistic botanical pairings that amplify efficacy while mitigating individual compound limitations.
View technical scope →
Direct supply of standardized concentrated liquids, atomized extract powders, purified paste concentrates, and vacuum-distilled essential oils. Sealed under strict GMP conditions with non-disclosure protection.
Request specifications →
End-to-end commercial supply across diverse consumer delivery vehicles: liquid shots, vegetarian two-piece capsules, lipid-core softgels, chewable tablets, fast-dissolving effervescents, and dry granules.
Request specifications →A deterministic, audit-proof project management pathway engineered to minimize client capital expenditure risk and eliminate formulation failure during scale-up.
Identifying target phytochemical active markers, verifying geo-botanical origin authenticity, and selecting harvest windows with peak secondary metabolite concentration.
Deliverable: Phytochemical Target Feasibility & Sourcing DossierEstablishing baseline HPTLC, HPLC-DAD, and GC-MS fingerprints, setting validated reference standards, LOD/LOQ validation, and drafting USP/Ph. Eur. compliant monograph drafts.
Deliverable: Validated Analytical Test Methods & Certificate of AnalysisDetermining solvent ratios, extraction temperature profiles, vacuum concentration limits, and crystallization thermodynamics on pilot scale before commercial build-out.
Deliverable: Pilot Batch Manufacturing Record (BMR) & CPP MatrixConducting in vitro receptor affinity screening, in vivo animal efficacy confirmation, and acute/sub-chronic safety evaluations to construct comprehensive safety margins.
Deliverable: Comprehensive Preclinical Safety & Efficacy PackageExecuting randomized double-blind placebo-controlled human clinical trials for structure-function health claims substantiation or formal Phase I–IV clinical programs for NDAs.
Deliverable: Independent Clinical Study Report (CSR) with Raw DataSeamless transfer to full commercial manufacturing of bulk standardized extract powders or ready-to-shelf finished dosage forms under stringent confidential non-disclosure covenants.
Deliverable: Validated Commercial Release Batches & Regulatory Filing PackPhytomedicinal extracts operate under distinct regulatory definitions depending on their destination category. We customize extraction ratios and analytical dossiers accordingly.
For brands competing in high-growth categories like cognitive health (nootropics), blood glucose management, sleep architecture, and metabolic vitality. We engineer standardized extracts with clinically verified bio-equivalency and documented structure-function support.
Navigating the rigorous thresholds of botanical drug applications (FDA Botanical Guidance / NMPA Class 1). Leveraging our experience in modernizing 83 classic hospital formulas and developing 22 new registered medicines to deliver rock-solid CMC and multi-target pharmacodynamic files.
Supplying multinational cosmetics corporations with purified, color-stabilized, and odor-neutralized natural active ingredients. Backed by human skin patch irritation safety testing, in vitro transdermal permeability profiling, and validated anti-collagenase efficacy data.
Our collaborative research, analytical testing, and contract manufacturing directly empower China’s foremost state pharmaceutical groups, listed biotechs, and Grade-3A clinical hospitals.
Tongrentang Group
CR Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical
Dihon Pharmaceutical
Golden Throat Group
Yangtzi River Pharma
Beihai Gofar Biological
Humanwell Healthcare
SCIMYTH Pharma Group
Shandong Hanfang
Luoxin Pharmaceutical
Guangdong Zhongsheng
Hunan Brilliance Herbal
Apeloa Pharmaceutical
Heng Chang Pharma
Baotou TCM Co.
Kamp Medicine
Guangxi Santo Pharma
Hunan Kangshou Pharma
Jiangxi Juwang Industry
Beijing Tcmages Pharma
Guizhou Ruihe Pharma
Anhui CR Jinchan
Kangmei Pharmaceutical
Tianjicaotang Pharma
Jiangxi Kingstone Pharma
Shuguang Hospital TCM
Hunan Affiliated TCM
1st Hospital Hunan TCM
Direct scientific answers addressing intellectual property security, regulatory audit readiness, analytical transfer, and batch repeatability.
We execute strict bilateral Non-Disclosure and IP Assignment Agreements prior to evaluating any project brief. All contract research deliverables, molecular optimization routes, and customized process parameters become the client's sole exclusive property, segregated in air-gapped laboratory databases.
Our analytical suites deploy HPTLC for fingerprint identity, reverse-phase UPLC/HPLC-DAD for quantitative marker assays, and GC-MS/MS for residual volatile analysis. Every method is validated under ICH Q2(R1) guidelines, establishing repeatability, linearity, LOD/LOQ, and inter-day precision.
Yes. Our pilot plant bridges the gap between laboratory benchtop assays (500g–5kg) and multi-ton industrial campaigns. Our engineers develop Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) that ensure zero degradation of active compounds during continuous large-scale runs.
In vitro bioassays, primary cell cultures, and standard toxicity screenings are performed in our own GLP analytical facilities. Formal animal efficacy studies and Phase I–IV human clinical trials are conducted in direct partnership with our affiliated Grade-3A University Hospitals under GCP compliance.
For active botanical raw materials, we supply high-concentration liquid tinctures, vacuum-dried crystal powders, pastes, and volatile essential oils. For finished retail brands, we formulate and pack hard-shell capsules, softgels, effervescent tablets, oral liquids, and water-soluble sachets.
We perform multi-region harvest sampling to map seasonal potency curves across varying growth micro-climates. Our standardization protocols employ natural blending formulas and concentration adjustments so finished extracts maintain strict label claim consistency regardless of seasonal weather shifts.
Accelerate your clinical pipeline by selecting verified botanical research modules and custom CDMO production runs.
Whether you require targeted active marker fractionating, custom monograph development, or commercial GMP botanical contract manufacturing, our team delivers auditable results on strict timelines.
